Home
Balaxi Pharmaceuticals Ltd EPS

Balaxi Pharmaceuticals Ltd
NSE: BALAXI
EPS
Key Highlights
- The Earning per Share of Balaxi Pharmaceuticals Ltd is ₹ 4.77 as of 21 Feb 25 .
- The earning per share of Balaxi Pharmaceuticals Ltd changed from ₹ -40.49 to ₹ 0.97 over 7 quarters. This represents a CAGR of NaN% .
Historical Earning per Share of Balaxi Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Balaxi Pharmaceuticals Ltd
Company Fundamentals for Balaxi Pharmaceuticals Ltd
Market Cap
312 Cr
EPS
4.8
P/E Ratio (TTM)
11.9
P/B Ratio (TTM)
1.5
Day’s High
57.95
Day’s Low
55.05
DTE
0.1
ROE
16.5
52 Week High
151.45
52 Week Low
51.0
ROCE
16.4
Market Price of Balaxi Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 56.68 |
20 Feb 2025 | 55.77 |
19 Feb 2025 | 53.94 |
18 Feb 2025 | 52.18 |
17 Feb 2025 | 55.87 |
14 Feb 2025 | 60.16 |
13 Feb 2025 | 60.86 |
12 Feb 2025 | 66.08 |
11 Feb 2025 | 65.11 |
10 Feb 2025 | 68 |
SWOT Analysis Of Balaxi Pharmaceuticals Ltd
BlinkX Score for Balaxi Pharmaceuticals Ltd
Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd
Market Value
₹ 313
Asset Value
Value addition
0.5 X
₹ 210
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Balaxi Pharmaceuticals Ltd | 312.92 | 4.77 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Balaxi Pharmaceuticals Ltd | 312.92 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Balaxi Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Balaxi Pharmaceuticals Ltd
Historical Revenue of Balaxi Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Balaxi Pharmaceuticals Ltd
Historical EBITDA of Balaxi Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Balaxi Pharmaceuticals Ltd
Historical Net Profit of Balaxi Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Balaxi Pharmaceuticals Ltd
Dividend Payout Over Time
Balaxi Pharmaceuticals Ltd News Hub
Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter
Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga
Read more
02 Aug 24
Balaxi Pharmaceuticals to conduct AGM
Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he
Read more
01 Aug 24
Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September
Read more
05 Nov 24
Balaxi Pharmaceuticals announces board meeting date
Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20
Read more
30 Oct 24